Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2025-12-25 @ 9:24 PM
NCT ID: NCT03612856
Description: None
Frequency Threshold: 0
Time Frame: Adverse event data was collected from study check in (Day -8) through the final follow up (Day 12) for a total of 21 days.
Study: NCT03612856
Study Brief: Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AB023 (Xisomab 3G3)- Dose 1 Participants will receive a single dose of 0.25 mg/kg xisomab 3G3. AB023- Dose 1: Participants will receive a single dose of 0.25 mg/kg AB023. 0 None 0 8 2 8 View
AB023 (Xisomab 3G3)- Dose 2 Participants will receive a single dose of 0.5 mg/kg xisomab 3G3. AB023-Dose 2: Participants will receive a single dose of 0.5 mg/kg AB023. 0 None 0 8 0 8 View
Placebo Participants will receive a single dose of placebo. placebo: Participants will receive a single dose of placebo. 0 None 0 8 1 8 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Viral gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (21.1) View